US12577238B2ActiveUtilityA1
Compositions and methods for modulating inflammatory and degenerative disorder
Est. expiryFeb 28, 2038(~11.6 yrs left)· nominal 20-yr term from priority
Inventors:EVSEENKO DENIS
C07D 401/12A61K 45/06A61K 31/444A61K 31/4439A61K 9/16A61K 9/0019A61P 19/02A61K 9/5031A61K 31/506A61P 35/00C07D 277/42C07D 213/81C07D 417/14C07D 413/12C07D 417/12A61K 31/427
70
PatentIndex Score
0
Cited by
24
References
6
Claims
Abstract
The disclosure provides compounds and method useful for modulating gp130 biological activity. The disclosure also provides methods and compositions for treating disease and disorders associated with gp130 activity, particularly those associated with inflammation.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating osteoarthritis comprising injecting into a joint space of a human subject a therapeutically effective amount of microspheres containing compound 805:
2 . The method of claim 1 , wherein the microspheres further comprises hyaluronic acid.
3 . The method of claim 1 , further comprising contacting the human subject with an additional therapeutic compound selected from the group consisting of glucocorticoid treatments, steroidals, local or general anesthetics, NSAIDS, low molecular weight heparins, anti-inflammatoireanti-TNF antibodies and soluble TNF receptors and cyclooxygenase-2 inhibitors.
4 . The method of claim 1 , wherein compound 805 is present at a concentration less than about 10 mg/kg of body weight.
5 . The method of claim 1 , wherein the microspheres are sterilized by filtration.
6 . The method of claim 1 , wherein the microspheres are formulated for injection into a knee or hip.Join the waitlist — get patent alerts
Track US12577238B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.